Age: 59.0
Sex: U
Vaccine: COVID19
Symptoms: Chest pain, Condition aggravated, Dyspnoea, Ejection fraction, Ejection fraction decreased
Clinical narrative: severe chest pains; shortness of breath start a little and seemed to be getting worse; shortness of breath start a little and seemed to be getting worse; EF factor was 35; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 59 year-old patient received bnt162b2 (BNT162B2), administered in arm left, administration date 06May2021 (Lot number: EW0168) at the age of 59 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "COPD" (unspecified if ongoing); "Barrett's esophagus" (unspecified if ongoing); "Heart attack 2018", start date: 2018 (unspecified if ongoing). No known allergies. Concomitant medication(s) included: DILANTIN [PHENYTOIN SODIUM]; ENTRESTO; NEXIUM [ESOMEPRAZOLE MAGNESIUM]; ANORO inhaler; ASPIRIN [ACETYLSALICYLIC ACID]. Vaccination history included: Bnt162b2 (Dose Number: 1 Batch/Lot No: EN6205, Location of injection: Arm Left), administration date: 15Apr2021, when the patient was 59 years old, for COVID-19 Immunization. The patient had not received any other vaccine in four weeks prior to vaccination. Patient had no COVID infection prior vaccination. The following information was reported: CHEST PAIN (hospitalization, disability, life threatening) with onset 06May2021, outcome "not recovered", described as "severe chest pains"; DYSPNOEA (hospitalization, disability, life threatening), CONDITION AGGRAVATED (hospitalization, disability, life threatening) all with onset 06May2021, outcome "not recovered" and all described as "shortness of breath start a little and seemed to be getting worse"; EJECTION FRACTION DECREASED (hospitalization, disability, life threatening) with onset 06May2021, outcome "not recovered", described as "EF factor was 35"; The patient was hospitalized for chest pain, dyspnoea, condition aggravated, ejection fraction decreased (hospitalization duration: 3 day(s)). The events "severe chest pains", "shortness of breath start a little and seemed to be getting worse", "shortness of breath start a little and seemed to be getting worse", "EF factor was 35" were evaluated at the physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: ejection fraction: (06May2021) 35; sars-cov-2 test: (11Nov2021) negative; (23Nov2021) negative. It was unknown if therapeutic measures were taken as a result of chest pain, dyspnoea, condition aggravated, ejection fraction decreased. The patient stated that, she was doing great for two years after having heart attack her ejection fraction was good at 45 and living a great life. She had toe second shot she had severe chest pains thought we would have to call emergency numbers. Slowly after that her shortness of breath started a little and seemed to be getting worse. Finally backed forth with doctors it came to a point she had to go to ER. She had no blockage, but EF factor was 35. Now they are trying oxygen to help me. She was never on oxygen. Nobody could explain why this happened. She said after the shot things went downhill. AE resulted in emergency room and doctor visits.